Techne (TECH) came out with quarterly earnings of $0.42 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.42 per share a year ago. These figures are adjusted for ...

Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 2.8% in the afternoon session after Baird adjusted its price target on the company, signaling a more positive outlook. The investment ...

Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Techne (TECH) reports results for the quarter ended September 2025. While this widely-known consensus outlook ...

The Casa Pop-Up Desk includes a wireless keyboard and trackpad and folds down into a book-like case when not in use. The Casa Pop-Up Desk includes a wireless keyboard and trackpad and folds down into ...

The DCF model implemented in this article suggests that Bio-Techne is overvalued by 34.53%. Bio-Techne has allocated significant financial resources to capex. Due to these resources, its revenues ...

Bio-Techne’s TECH GMP reagents, including GMP proteins and small molecules, remain a cornerstone of its cell therapy offering. Acquisitions have continued to play an important role in the company’s ...